Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denise L Faustman

Showing results (51-60 of 70) with videos related to

Pageof 7
Sort By:
Journal of Leukocyte Biology|March 24, 2020
Optimizing TNFR2 antagonism for immunotherapy with tumor microenvironment specificityMichael Yang, Lisa Tran, Heather Torrey, et al.
Infection and Immunity|July 22, 2020
Brucella abortus and Pregnancy in Mice: Impact of Chronic Infection on Fertility and the Role of Regulatory T Cells in Tissue ColonizationShakirat A Adetunji, Denise L Faustman, L Garry Adams, et al.
International Immunopharmacology|November 18, 2021
A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancerMengmeng Jiang, Jia Liu, De Yang, et al.
Iscience|October 14, 2021
Bacillus Calmette-Guerin 's beneficial impact on glucose metabolism: evidence for broad based applicationsGabriella F Shpilsky, Hiroyuki Takahashi, Anna Aristarkhova, et al.
Plos One|August 21, 2012
Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetesDenise L Faustman, Limei Wang, Yoshiaki Okubo, et al.
The Journal of Rheumatology|October 17, 2009
Expression of proteasomal immunosubunit beta1i is dysregulated in inflammatory infiltrates of minor salivary glands in Sjogren's syndromeLars Morawietz, Lorena Martinez-Gamboa, Sonja Scheffler, et al.
NPJ Vaccines|June 29, 2018
Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinationsWillem M Kühtreiber, Lisa Tran, Taesoo Kim, et al.
Science Signaling|January 19, 2017
Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated TregsHeather Torrey, John Butterworth, Toshiyuki Mera, et al.
Iscience|May 8, 2020
BCG Vaccinations Upregulate Myc, a Central Switch for Improved Glucose Metabolism in DiabetesWillem M Kühtreiber, Hiroyuki Takahashi, Ryan C Keefe, et al.
Iscience|July 26, 2024
Late in the US pandemic, multi-dose BCG vaccines protect against COVID-19 and infectious diseasesWillem M Kühtreiber, Emma R Hostetter, Grace E Wolfe, et al.
Pageof 7

Showing results (51-60 of 70) with videos related to

Sort By:
Pageof 7
Journal of Leukocyte Biology|March 24, 2020
Optimizing TNFR2 antagonism for immunotherapy with tumor microenvironment specificityMichael Yang, Lisa Tran, Heather Torrey, et al.
Infection and Immunity|July 22, 2020
Brucella abortus and Pregnancy in Mice: Impact of Chronic Infection on Fertility and the Role of Regulatory T Cells in Tissue ColonizationShakirat A Adetunji, Denise L Faustman, L Garry Adams, et al.
International Immunopharmacology|November 18, 2021
A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancerMengmeng Jiang, Jia Liu, De Yang, et al.
Iscience|October 14, 2021
Bacillus Calmette-Guerin 's beneficial impact on glucose metabolism: evidence for broad based applicationsGabriella F Shpilsky, Hiroyuki Takahashi, Anna Aristarkhova, et al.
Plos One|August 21, 2012
Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetesDenise L Faustman, Limei Wang, Yoshiaki Okubo, et al.
The Journal of Rheumatology|October 17, 2009
Expression of proteasomal immunosubunit beta1i is dysregulated in inflammatory infiltrates of minor salivary glands in Sjogren's syndromeLars Morawietz, Lorena Martinez-Gamboa, Sonja Scheffler, et al.
NPJ Vaccines|June 29, 2018
Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinationsWillem M Kühtreiber, Lisa Tran, Taesoo Kim, et al.
Science Signaling|January 19, 2017
Targeting TNFR2 with antagonistic antibodies inhibits proliferation of ovarian cancer cells and tumor-associated TregsHeather Torrey, John Butterworth, Toshiyuki Mera, et al.
Iscience|May 8, 2020
BCG Vaccinations Upregulate Myc, a Central Switch for Improved Glucose Metabolism in DiabetesWillem M Kühtreiber, Hiroyuki Takahashi, Ryan C Keefe, et al.
Iscience|July 26, 2024
Late in the US pandemic, multi-dose BCG vaccines protect against COVID-19 and infectious diseasesWillem M Kühtreiber, Emma R Hostetter, Grace E Wolfe, et al.
Pageof 7